Comparison of the Effects of Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma between Patients with and without Extrahepatic Metastases

BACKGROUND/AIMS: Sorafenib is a standard treatment for advanced hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] stage C). However, transarterial chemoembolization (TACE) has also been widely used as a treatment for patients with advanced HCC, even if they have extrahepatic metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jeong-Ju, Lee, Jeong-Hoon, Lee, Sang Hwan, Lee, Minjong, Lee, Dong Hyeon, Cho, Yuri, Lee, Yun Bin, Yu, Su Jong, Kim, Hyo-Cheol, Kim, Yoon Jun, Yoon, Jung-Hwan, Kim, Chung Yong, Lee, Hyo-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245068/
https://www.ncbi.nlm.nih.gov/pubmed/25427152
http://dx.doi.org/10.1371/journal.pone.0113926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245068/
https://www.ncbi.nlm.nih.gov/pubmed/25427152
http://dx.doi.org/10.1371/journal.pone.0113926

Ejemplares similares